Related Experiment Video
Updated: Jul 15, 2025
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on
Julie Krainer1, Michaela Hendling1, Sandra Siebenhandl1
1Center for Health and Bioresources, Molecular Diagnostics, AIT Austrian Institute of Technology GmbH, Giefinggasse 4, 1210 Vienna, Austria.
Insights
Systemic juvenile idiopathic arthritis (SJIA) involves delayed diagnosis and unclear classification. This study identified novel immune responses and proteins, including those in the NF-κB pathway, offering new insights into SJIA pathogenesis.
Area of Science:
- Immunology
- Rheumatology
- Pediatrics
Background:
- Systemic juvenile idiopathic arthritis (SJIA) is a severe childhood rheumatic disease.
- SJIA diagnosis is often delayed, and its classification as autoinflammatory or autoimmune is debated.
- Understanding SJIA's immunological underpinnings is crucial for improved diagnostics and treatment.
Purpose of the Study:
- To investigate the immunological responses in SJIA patients.
- To identify autoantibodies and dysregulated proteins involved in SJIA pathogenesis.
- To explore potential therapeutic targets by analyzing immune reactivity.
Main Methods:
- Utilized human proteome arrays with immobilized recombinant proteins.
- Analyzed immunological responses and autoantibody profiles in SJIA patients.
- Performed group comparisons to identify differentially reactive antigens.
Main Results:
- Identified several antigens involved in inflammatory processes.
- Observed high reactivity against proteins within the NF-κB pathway.
- Detected differentially reactive antigens (DIRAGs) also implicated in rheumatoid arthritis.
Conclusions:
- Highlighted novel proteins and pathways potentially dysregulated in SJIA.
- Provided a unique approach to unraveling SJIA pathogenesis.
- Suggested potential links between SJIA and rheumatoid arthritis immune responses.
Abstract:
Systemic juvenile idiopathic arthritis (SJIA) is a severe rheumatic disease in children. It is a subgroup of juvenile idiopathic arthritis (JIA; MIM #604302), which is the most common rheumatic disease in children. The diagnosis of SJIA often comes with a significant delay, and the classification between autoinflammatory and autoimmune disease is still discussed. In this study, we analyzed the immunological responses of patients with SJIA, using human proteome arrays presenting immobilized recombinantly expressed human proteins, to analyze the involvement of autoantibodies in SJIA. Results from group comparisons show several differentially reactive antigens involved in inflammatory processes. Intriguingly, many of the identified antigens had a high reactivity against proteins involved in the NF-κB pathway, and it is also notable that many of the detected DIRAGs are described as dysregulated in rheumatoid arthritis. Our data highlight novel proteins and pathways potentially dysregulated in SJIA and offer a unique approach to unraveling the underlying disease pathogenesis in this chronic arthropathy.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
10:16Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Related Concept Videos
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
01:20The JAK-STAT Signaling Pathway
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests